095618520	095618520	CD	B-NP	O
|	|	NN	I-NP	O
MHR	MHR	NN	I-NP	O
|	|	NN	I-NP	O
62562649	62562649	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
580543	580543	CD	B-NP	O
|	|	CC	I-NP	O
1/27/2002	1/27/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
,	,	,	O	O
osteomyelitis	osteomyelitis	NN	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/8/2002	2/8/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/13/2002	11/13/2002	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
DALLY	DALLY	NNP	B-NP	O
,	,	,	O	O
SANTOS	SANTOS	NNP	B-NP	O
199-46-63-9	199-46-63-9	CD	I-NP	O
Scot	Scot	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/24/02	10/24/02	CD	B-NP	O
AT	AT	NN	I-NP	O
09	09	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
SNF/rehab	SNF/rehab	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KALBERG	KALBERG	NNP	B-NP	O
,	,	,	O	O
ART	ART	NNP	B-NP	O
DOMENIC	DOMENIC	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Skilled	Skille	VBN	B-VP	O
Nursing	Nurse	VBG	B-VP	O
Facility	Facility	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
BUFFERED	BUFFERED	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
GLYBURIDE	GLYBURIDE	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
HEPARIN	HEPARIN	NNP	I-NP	O
5	5	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
U	U	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
IMIPENEM-CILASTATIN	IMIPENEM-CILASTATIN	NNP	I-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
IV	IV	CD	B-NP	O
Q6H	Q6H	NN	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
5/29	5/29	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
continue	continue	VB	B-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
3	3	CD	I-NP	O
weeks	week	NNS	I-NP	O
until	until	IN	B-PP	O
September	September	NNP	B-NP	O
This	This	NNP	I-NP	O
order	order	NN	I-NP	O
has	have	VBZ	B-VP	O
received	receive	VBN	I-VP	O
infectious	infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
approval	approval	NN	I-NP	O
from	from	IN	B-PP	O
TURRI	TURRI	NNP	B-NP	O
,	,	,	O	O
DOMENIC	DOMENIC	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/5/02	7/5/02	CD	B-NP	O
by	by	IN	B-PP	O
DEVOS	DEVOS	NN	B-NP	B-protein
,	,	,	O	O
MARVIN	MARVIN	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
IMIPENEM	IMIPENEM	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
IMIPENEM	IMIPENEM	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
12	12	CD	B-NP	O
LISINOPRIL	LISINOPRIL	NN	I-NP	O
20	20	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
PREMPRO	PREMPRO	NN	I-NP	O
0.625	0.625	CD	B-NP	O
MG/2	MG/2	NN	I-NP	O
.5	.5	CD	B-NP	O
MG	MG	NN	I-NP	O
1	1	CD	B-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
PRILOSEC	PRILOSEC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/3/02	4/3/02	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
GLYBURIDE	GLYBURIDE	NNP	B-NP	O
&	&	CC	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
GLYBURIDE	GLYBURIDE	NNP	B-NP	O
&	&	CC	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
requires	require	VBZ	B-VP	O
both	both	CC	O	O
DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
RETURN	RETURN	NN	I-NP	O
TO	TO	NN	I-NP	O
WORK	WORK	NN	I-NP	O
:	:	:	O	O
After	After	IN	B-PP	O
D/C	D/C	NN	B-NP	O
from	from	IN	B-PP	O
SNF	SNF	NNP	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Leo	Leo	NNP	I-NP	O
Gerwe	Gerwe	NNP	I-NP	O
,	,	,	O	O
ortho	ortho	JJ	B-NP	O
2/25/02	2/25/02	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Alva	Alva	NNP	I-NP	O
Tscrious	Tscrious	NNP	I-NP	O
,	,	,	O	O
ID	ID	NNP	B-NP	O
10/20/02	10/20/02	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Lucy	Lucy	NNP	I-NP	O
7/30/02	7/30/02	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Cephalosporins	Cephalosporins	NNP	B-NP	O
,	,	,	O	O
Fluoroquinolones	Fluoroquinolones	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
quinolones	quinolone	NNS	I-NP	O
-RRB-	-RRB-	POS	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
cellulitis	cellulitis	NN	B-NP	O
,	,	,	O	O
osteomyelitis	osteomyelitis	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
,	,	,	O	O
osteomyelitis	osteomyelitis	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
diabetes	diabete	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
edema	edema	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
peripheral	peripheral	JJ	I-NP	O
edema	edema	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
recurrent	recurrent	JJ	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
mitral	mitral	JJ	I-NP	O
prolapse	prolapse	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
mitral	mitral	JJ	I-NP	B-protein
valve	valve	NN	I-NP	I-protein
prolapse	prolapse	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	O	I-protein
uti	uti	AFX	O	B-DNA
-LRB-	-LRB-	HYPH	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
atopic	atopic	JJ	I-NP	O
dermatitis	dermatitis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
dermatitis	dermatitis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
LENIs	LENIs	NNP	I-NP	O
ABI	ABI	NNP	I-NP	O
PVRs	PVRs	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
57	57	CD	B-NP	O
yo	yo	NN	I-NP	O
female	female	JJ	I-NP	O
h/o	h/o	NN	I-NP	O
NIDDM	NIDDM	NN	I-NP	O
,	,	,	O	O
recurrent	recurrent	JJ	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
,	,	,	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
2-3	2-3	CD	B-NP	O
days	day	NNS	I-NP	O
worsening	worsen	VBG	B-VP	O
cellulitis	cellulitis	NN	B-NP	O
of	of	IN	B-PP	O
LE	LE	NN	B-NP	O
b/l	b/l	NN	I-NP	O
.	.	.	O	O

starting	start	VBG	B-VP	O
11/14	11/14	CD	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
getting	get	VBG	I-VP	O
various	various	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
for	for	IN	B-PP	O
left	left	JJ	B-NP	O
LE	LE	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
,	,	,	O	O
starting	start	VBG	B-VP	O
on	on	IN	B-PP	O
Keflex	Keflex	NNP	B-NP	O
,	,	,	O	O
switched	switch	VBD	B-VP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
Clinda	Clinda	NNP	I-NP	O
for	for	IN	B-PP	O
osteo	osteo	RB	B-NP	O
diagnosed	diagnose	VBN	I-NP	O
8/22	8/22	CD	I-NP	O
,	,	,	O	O
switched	switch	VBD	B-VP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
Ancef	Ancef	NN	I-NP	O
with	with	IN	B-PP	O
PICC	PICC	NN	B-NP	O
after	after	IN	B-SBAR	O
osteo	osteo	NN	B-NP	B-protein
diagnosed	diagnose	VBD	B-VP	I-protein
10/18/02	10/18/02	CD	B-NP	I-protein
with	with	IN	B-PP	O
PO	PO	NN	B-NP	B-protein
ciproflox	ciproflox	NN	I-NP	I-protein
.	.	.	O	O

3	3	CD	B-NP	O
days	day	NNS	I-NP	O
PTA	PTA	NN	I-NP	O
patient	patient	NN	I-NP	O
getting	get	VBG	B-VP	O
IV	IV	CD	B-NP	O
vanc	vanc	NN	I-NP	O
through	through	IN	B-PP	O
PICC	PICC	NN	B-NP	B-protein
with	with	IN	B-PP	O
no	no	DT	B-NP	O
success	success	NN	I-NP	O
.	.	.	O	O

Erythema	Erythema	NN	B-NP	O
,	,	,	O	O
tenderness	tenderness	NN	B-NP	O
,	,	,	O	O
warmth	warmth	NN	B-NP	O
worse	worse	JJR	B-ADJP	O
on	on	IN	B-PP	O
LLE	LLE	NN	B-NP	O
and	and	CC	O	O
now	now	RB	B-VP	O
spreading	spread	VBG	I-VP	O
to	to	TO	B-PP	O
RLE	RLE	NN	B-NP	B-protein
.	.	.	O	O

Patient	Patient	NN	B-NP	O
otherwise	otherwise	RB	B-ADJP	O
completely	completely	RB	I-ADJP	O
asymptomatic	asymptomatic	JJ	I-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
F/C/N	F/C/N	NN	I-NP	B-protein
/	/	SYM	B-NP	O
N/V	N/V	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
CP/SOB/dysuria	CP/SOB/dysuria	NN	I-NP	O
/	/	SYM	B-NP	O
diarrhea/dizzy	diarrhea/dizzy	NN	I-NP	O
.	.	.	O	O

VSS	VSS	NN	B-NP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
floor	floor	NN	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
consulted	consult	VBD	B-VP	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
imepenem/cilistatin	imepenem/cilistatin	NN	I-NP	O
started	start	VBD	B-VP	O
500	500	CD	B-NP	O
q6h	q6h	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
got	get	VBD	B-VP	O
LENI	LENI	NNP	B-NP	O
's	's	POS	B-NP	O
HSD2	HSD2	NN	I-NP	B-protein
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
normal	normal	JJ	B-NP	O
b/l	b/l	NN	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
got	get	VBD	B-VP	O
ABI/PVR	ABI/PVR	NN	B-NP	O
,	,	,	O	O
antibiotics	antibiotic	NNS	B-NP	O
continued	continue	VBN	B-VP	O
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
,	,	,	O	O
less	less	JJR	B-NP	O
erythema/tenderness	erythema/tenderness	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
ulcer	ulcer	NN	B-NP	O
to	to	TO	B-VP	O
tendon	tendon	VB	I-VP	O
on	on	IN	B-PP	O
left	left	JJ	B-NP	O
lateral	lateral	JJ	I-NP	O
foot	foot	NN	I-NP	O
still	still	RB	B-ADJP	O
present	present	JJ	I-ADJP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
to	to	TO	B-PP	O
SNF	SNF	NN	B-NP	B-protein
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
imepenem/cilistatin	imepenem/cilistatin	NN	I-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
with	with	IN	B-PP	O
Ortho	Ortho	NNP	B-NP	O
clinic	clinic	NN	I-NP	O
,	,	,	O	O
ID	ID	NN	B-NP	O
clinic	clinic	NN	I-NP	O
and	and	CC	O	O
primary	primary	JJ	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Klawinski	Klawinski	NNP	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNP	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
continue	continue	VB	B-VP	O
IV	IV	CD	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
3	3	CD	I-NP	O
weeks	week	NNS	I-NP	O
until	until	IN	B-PP	O
October	October	NNP	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Going	Go	VBG	B-VP	O
to	to	TO	B-PP	O
SNF	SNF	NN	B-NP	B-protein
with	with	IN	B-PP	O
PICC	PICC	NN	B-NP	B-protein
and	and	CC	O	O
IV	IV	CD	B-NP	O
imepenem/cilistatin	imepenem/cilistatin	NN	I-NP	O
To	To	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Tacderan	Tacderan	NNP	I-NP	O
,	,	,	O	O
7/21/02	7/21/02	CD	B-NP	O
1	1	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
PM	PM	NN	I-NP	O
To	To	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Ortho	Ortho	NNP	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Weir	Weir	NNP	I-NP	O
,	,	,	O	O
4/24/02	4/24/02	CD	B-NP	O
9AM	9AM	NN	I-NP	O
To	To	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
ID	ID	NNP	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Elroy	Elroy	NNP	I-NP	O
Proue	Proue	NNP	I-NP	O
,	,	,	O	O
4/2/02	4/2/02	CD	B-NP	O
10AM	10AM	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
JANNEY	JANNEY	NNP	B-NP	O
,	,	,	O	O
VON	VON	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
EQ50	EQ50	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/24/02	10/24/02	CD	I-NP	O
@	@	IN	B-NP	O
10	10	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

